Post-Coronavirus Disease 2019 (COVID-19) Antibody levels in End-Stage Renal Disease (ESRD) patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20211005004

Enrollment

Registered

2021-10-05

Start date

2021-10-11

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease patients with renal replacement therapy recovered from COVID-19 ESRD End stage kidney disease COVID-19 SARS-CoV-2 Post COVID-19 RRT Renal replacement therapy

Interventions

End stage renal disease patients who recovered from COVID-19

Basic Science

ESRD

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age 18 years or more 2. End stage renal disease patient 3. Recovered from COVID-19 in Bamrasnaradura Infectious Diseases Institute 4. Informed consent for participation

Exclusion criteria

Exclusion criteria: 1. Develop end stage renal disease after COVID-19 2. Received any COVID-19 vaccination

Design outcomes

Primary

Measure	Time frame
SARS-CoV-2 Antibody 0, 1, 3, 6 months after recovered from COVID-19 ELISA	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactWisit Prasitsirikul

Bamrasnaradura Infectious Diseases Institute

drwisit_p@yahoo.com029511170

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026